9/5/26
CD Private Equity Fund III (CD3.AX) Thesis Recent performance metrics indicate a significant decline in revenue and NAV, raising concerns about the fund's ability to attract new investments.
What Moves the Stock 01 Performance of portfolio companies in the Australian private equity market 02 Changes in investor sentiment towards private equity as an asset class 03 Regulatory changes impacting asset management fees 04 Market liquidity conditions affecting fundraising capabilities 05 Management fees from private equity investments - 100% 06 Increased focus on technology investments within private equity 07 Growing interest in sustainable and impact investing 0.7 0.8 0.8 0.8 0.9 0.82 CD3.AX Daily 0.82 Apr '26 Jun '26 Jul '26 Sep '26
My Notes "Management acknowledged, 'We need to reassess our investment strategy to stabilize performance.'" Moat: The fund's focus on operational improvements in underperforming assets provides a moderate level of competitive advantage. value - Investors looking for turnaround opportunities in underperforming assets may find CD3.AX appealing. Rising interest rates can increase the cost of capital for portfolio companies… Watch on earnings: NAV growth rate, Management fee revenue trends, Portfolio company performance metrics. One Sentence Summary: CD Private Equity Fund III: the story is balanced — performance of portfolio companies in the australian private equity market.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
